REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka "Eskulap". Czech. sp. j. (Poland)

Main Activities: Department Stores
Full name: Apteka "Eskulap". Czech. sp. j. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Apteka "Eskulap". Czech. sp. j. is a company in Poland, with a head office in Wodzislaw Slaski. The enterprise operates in the Department Stores industry. The enterprise was incorporated on November 27, 2001. There are currently 101 - 250 (2013) people employed by Apteka "Eskulap". Czech. sp. j.. In 2024, the company reported a net sales revenue increase of 401.42%. There was a total growth of 14.02% in Apteka "Eskulap". Czech. sp. j.’s total assets over the same period. The net profit margin of Apteka "Eskulap". Czech. sp. j. decreased by 1.33% in 2024.

Headquarters
Ul. Ksieznej Konstancji 4
Wodzislaw Slaski; Slaskie; Postal Code: 44-300

Contact Details: Purchase the Apteka "Eskulap". Czech. sp. j. report to view the information.

Basic Information
Total Employees:
Purchase the Apteka "Eskulap". Czech. sp. j. report to view the information.
Financial Auditors:
Purchase the Apteka "Eskulap". Czech. sp. j. report to view the information.
Incorporation Date:
November 27, 2001
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka "Eskulap". Czech. sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
401.42%
Total operating revenue
401.42%
Operating profit (EBIT)
162.45%
EBITDA
172.78%
Net Profit (Loss) for the Period
136.95%
Total Assets
14.02%
Total Equity
5.7%
Operating Profit Margin (ROS)
-1.31%
Net Profit Margin
-1.33%
Return on Equity (ROE)
26.3%
Quick Ratio
-1.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?